BridgeBio Pharma (BBIO) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.42% |
| Dec 31, 2025 | -43.14% |
| Sep 30, 2025 | -58.57% |
| Jun 30, 2025 | -64.34% |
| Mar 31, 2025 | -57.94% |
| Dec 31, 2024 | -8.54% |
| Sep 30, 2024 | -2.00% |
| Jun 30, 2024 | 19.86% |
| Mar 31, 2024 | 14.51% |
| Dec 31, 2023 | -8.02% |
| Sep 30, 2023 | -5.95% |
| Jun 30, 2023 | -33.20% |
| Mar 31, 2023 | -16.56% |
| Dec 31, 2022 | -43.41% |
| Sep 30, 2022 | -52.67% |
| Jun 30, 2022 | -121.54% |
| Mar 31, 2022 | -167.36% |
| Dec 31, 2021 | -915.96% |
| Sep 30, 2021 | -442.35% |
| Jun 30, 2021 | -240.50% |
| Mar 31, 2021 | -186.71% |
| Dec 31, 2020 | -77.57% |
| Sep 30, 2020 | -58.63% |
| Jun 30, 2020 | 54.08% |
| Mar 31, 2020 | 44.63% |
| Dec 31, 2019 | 25.58% |
| Sep 30, 2019 | 214.51% |
| Jun 30, 2019 | 3.40% |
| Dec 31, 2018 | 326.99% |